Global Infectious Disease Biomarker Testing Supply, Demand and Key Producers, 2023-2029

Description

The global Infectious Disease Biomarker Testing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Infectious Disease Biomarker Testing demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Infectious Disease Biomarker Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Infectious Disease Biomarker Testing that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Infectious Disease Biomarker Testing total market, 2018-2029, (USD Million)
Global Infectious Disease Biomarker Testing total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Infectious Disease Biomarker Testing total market, key domestic companies and share, (USD Million)
Global Infectious Disease Biomarker Testing revenue by player and market share 2018-2023, (USD Million)
Global Infectious Disease Biomarker Testing total market by Type, CAGR, 2018-2029, (USD Million)
Global Infectious Disease Biomarker Testing total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Infectious Disease Biomarker Testing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abacus Diagnostica, ALPCO, Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories and Danaher, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Infectious Disease Biomarker Testing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Infectious Disease Biomarker Testing Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Infectious Disease Biomarker Testing Market, Segmentation by Type
    PCR
    NGS
    ELISA or EIA
    IHC
    ISH
    Others

Global Infectious Disease Biomarker Testing Market, Segmentation by Application
    Hospitals and Clinics
    Diagnostic Centers
    Academic Research Institutes
    Others

Companies Profiled:
    Abacus Diagnostica
    ALPCO
    Abbott Laboratories
    Agilent Technologies
    Becton
    Dickinson and Company
    bioMérieux SA
    Bio-Rad Laboratories
    Danaher
    F. Hoffmann-La Roche
    Hologic
    PerkinElmer
    Qiagen
    Quest Diagnostics Incorporated
    Siemens Healthineers
    Thermo Fisher Scientific

Key Questions Answered
1. How big is the global Infectious Disease Biomarker Testing market?
2. What is the demand of the global Infectious Disease Biomarker Testing market?
3. What is the year over year growth of the global Infectious Disease Biomarker Testing market?
4. What is the total value of the global Infectious Disease Biomarker Testing market?
5. Who are the major players in the global Infectious Disease Biomarker Testing market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Infectious Disease Biomarker Testing Introduction
    1.2 World Infectious Disease Biomarker Testing Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Infectious Disease Biomarker Testing Total Market by Region (by Headquarter Location)
        1.3.1 World Infectious Disease Biomarker Testing Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Infectious Disease Biomarker Testing Market Size (2018-2029)
        1.3.3 China Infectious Disease Biomarker Testing Market Size (2018-2029)
        1.3.4 Europe Infectious Disease Biomarker Testing Market Size (2018-2029)
        1.3.5 Japan Infectious Disease Biomarker Testing Market Size (2018-2029)
        1.3.6 South Korea Infectious Disease Biomarker Testing Market Size (2018-2029)
        1.3.7 ASEAN Infectious Disease Biomarker Testing Market Size (2018-2029)
        1.3.8 India Infectious Disease Biomarker Testing Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Infectious Disease Biomarker Testing Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Infectious Disease Biomarker Testing Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Infectious Disease Biomarker Testing Consumption Value (2018-2029)
    2.2 World Infectious Disease Biomarker Testing Consumption Value by Region
        2.2.1 World Infectious Disease Biomarker Testing Consumption Value by Region (2018-2023)
        2.2.2 World Infectious Disease Biomarker Testing Consumption Value Forecast by Region (2024-2029)
    2.3 United States Infectious Disease Biomarker Testing Consumption Value (2018-2029)
    2.4 China Infectious Disease Biomarker Testing Consumption Value (2018-2029)
    2.5 Europe Infectious Disease Biomarker Testing Consumption Value (2018-2029)
    2.6 Japan Infectious Disease Biomarker Testing Consumption Value (2018-2029)
    2.7 South Korea Infectious Disease Biomarker Testing Consumption Value (2018-2029)
    2.8 ASEAN Infectious Disease Biomarker Testing Consumption Value (2018-2029)
    2.9 India Infectious Disease Biomarker Testing Consumption Value (2018-2029)

3 World Infectious Disease Biomarker Testing Companies Competitive Analysis
    3.1 World Infectious Disease Biomarker Testing Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Infectious Disease Biomarker Testing Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Infectious Disease Biomarker Testing in 2022
        3.2.3 Global Concentration Ratios (CR8) for Infectious Disease Biomarker Testing in 2022
    3.3 Infectious Disease Biomarker Testing Company Evaluation Quadrant
    3.4 Infectious Disease Biomarker Testing Market: Overall Company Footprint Analysis
        3.4.1 Infectious Disease Biomarker Testing Market: Region Footprint
        3.4.2 Infectious Disease Biomarker Testing Market: Company Product Type Footprint
        3.4.3 Infectious Disease Biomarker Testing Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Infectious Disease Biomarker Testing Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Infectious Disease Biomarker Testing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Infectious Disease Biomarker Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Infectious Disease Biomarker Testing Consumption Value Comparison
        4.2.1 United States VS China: Infectious Disease Biomarker Testing Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Infectious Disease Biomarker Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Infectious Disease Biomarker Testing Companies and Market Share, 2018-2023
        4.3.1 United States Based Infectious Disease Biomarker Testing Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Infectious Disease Biomarker Testing Revenue, (2018-2023)
    4.4 China Based Companies Infectious Disease Biomarker Testing Revenue and Market Share, 2018-2023
        4.4.1 China Based Infectious Disease Biomarker Testing Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Infectious Disease Biomarker Testing Revenue, (2018-2023)
    4.5 Rest of World Based Infectious Disease Biomarker Testing Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Infectious Disease Biomarker Testing Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Infectious Disease Biomarker Testing Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Infectious Disease Biomarker Testing Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 PCR
        5.2.2 NGS
        5.2.3 ELISA or EIA
        5.2.4 IHC
        5.2.5 ISH
        5.2.6 Others
    5.3 Market Segment by Type
        5.3.1 World Infectious Disease Biomarker Testing Market Size by Type (2018-2023)
        5.3.2 World Infectious Disease Biomarker Testing Market Size by Type (2024-2029)
        5.3.3 World Infectious Disease Biomarker Testing Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Infectious Disease Biomarker Testing Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospitals and Clinics
        6.2.2 Diagnostic Centers
        6.2.3 Academic Research Institutes
        6.2.4 Others
        6.2.5 Others
    6.3 Market Segment by Application
        6.3.1 World Infectious Disease Biomarker Testing Market Size by Application (2018-2023)
        6.3.2 World Infectious Disease Biomarker Testing Market Size by Application (2024-2029)
        6.3.3 World Infectious Disease Biomarker Testing Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Abacus Diagnostica
        7.1.1 Abacus Diagnostica Details
        7.1.2 Abacus Diagnostica Major Business
        7.1.3 Abacus Diagnostica Infectious Disease Biomarker Testing Product and Services
        7.1.4 Abacus Diagnostica Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Abacus Diagnostica Recent Developments/Updates
        7.1.6 Abacus Diagnostica Competitive Strengths & Weaknesses
    7.2 ALPCO
        7.2.1 ALPCO Details
        7.2.2 ALPCO Major Business
        7.2.3 ALPCO Infectious Disease Biomarker Testing Product and Services
        7.2.4 ALPCO Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 ALPCO Recent Developments/Updates
        7.2.6 ALPCO Competitive Strengths & Weaknesses
    7.3 Abbott Laboratories
        7.3.1 Abbott Laboratories Details
        7.3.2 Abbott Laboratories Major Business
        7.3.3 Abbott Laboratories Infectious Disease Biomarker Testing Product and Services
        7.3.4 Abbott Laboratories Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Abbott Laboratories Recent Developments/Updates
        7.3.6 Abbott Laboratories Competitive Strengths & Weaknesses
    7.4 Agilent Technologies
        7.4.1 Agilent Technologies Details
        7.4.2 Agilent Technologies Major Business
        7.4.3 Agilent Technologies Infectious Disease Biomarker Testing Product and Services
        7.4.4 Agilent Technologies Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Agilent Technologies Recent Developments/Updates
        7.4.6 Agilent Technologies Competitive Strengths & Weaknesses
    7.5 Becton
        7.5.1 Becton Details
        7.5.2 Becton Major Business
        7.5.3 Becton Infectious Disease Biomarker Testing Product and Services
        7.5.4 Becton Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Becton Recent Developments/Updates
        7.5.6 Becton Competitive Strengths & Weaknesses
    7.6 Dickinson and Company
        7.6.1 Dickinson and Company Details
        7.6.2 Dickinson and Company Major Business
        7.6.3 Dickinson and Company Infectious Disease Biomarker Testing Product and Services
        7.6.4 Dickinson and Company Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Dickinson and Company Recent Developments/Updates
        7.6.6 Dickinson and Company Competitive Strengths & Weaknesses
    7.7 bioMérieux SA
        7.7.1 bioMérieux SA Details
        7.7.2 bioMérieux SA Major Business
        7.7.3 bioMérieux SA Infectious Disease Biomarker Testing Product and Services
        7.7.4 bioMérieux SA Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 bioMérieux SA Recent Developments/Updates
        7.7.6 bioMérieux SA Competitive Strengths & Weaknesses
    7.8 Bio-Rad Laboratories
        7.8.1 Bio-Rad Laboratories Details
        7.8.2 Bio-Rad Laboratories Major Business
        7.8.3 Bio-Rad Laboratories Infectious Disease Biomarker Testing Product and Services
        7.8.4 Bio-Rad Laboratories Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Bio-Rad Laboratories Recent Developments/Updates
        7.8.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
    7.9 Danaher
        7.9.1 Danaher Details
        7.9.2 Danaher Major Business
        7.9.3 Danaher Infectious Disease Biomarker Testing Product and Services
        7.9.4 Danaher Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Danaher Recent Developments/Updates
        7.9.6 Danaher Competitive Strengths & Weaknesses
    7.10 F. Hoffmann-La Roche
        7.10.1 F. Hoffmann-La Roche Details
        7.10.2 F. Hoffmann-La Roche Major Business
        7.10.3 F. Hoffmann-La Roche Infectious Disease Biomarker Testing Product and Services
        7.10.4 F. Hoffmann-La Roche Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 F. Hoffmann-La Roche Recent Developments/Updates
        7.10.6 F. Hoffmann-La Roche Competitive Strengths & Weaknesses
    7.11 Hologic
        7.11.1 Hologic Details
        7.11.2 Hologic Major Business
        7.11.3 Hologic Infectious Disease Biomarker Testing Product and Services
        7.11.4 Hologic Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Hologic Recent Developments/Updates
        7.11.6 Hologic Competitive Strengths & Weaknesses
    7.12 PerkinElmer
        7.12.1 PerkinElmer Details
        7.12.2 PerkinElmer Major Business
        7.12.3 PerkinElmer Infectious Disease Biomarker Testing Product and Services
        7.12.4 PerkinElmer Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 PerkinElmer Recent Developments/Updates
        7.12.6 PerkinElmer Competitive Strengths & Weaknesses
    7.13 Qiagen
        7.13.1 Qiagen Details
        7.13.2 Qiagen Major Business
        7.13.3 Qiagen Infectious Disease Biomarker Testing Product and Services
        7.13.4 Qiagen Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Qiagen Recent Developments/Updates
        7.13.6 Qiagen Competitive Strengths & Weaknesses
    7.14 Quest Diagnostics Incorporated
        7.14.1 Quest Diagnostics Incorporated Details
        7.14.2 Quest Diagnostics Incorporated Major Business
        7.14.3 Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Product and Services
        7.14.4 Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Quest Diagnostics Incorporated Recent Developments/Updates
        7.14.6 Quest Diagnostics Incorporated Competitive Strengths & Weaknesses
    7.15 Siemens Healthineers
        7.15.1 Siemens Healthineers Details
        7.15.2 Siemens Healthineers Major Business
        7.15.3 Siemens Healthineers Infectious Disease Biomarker Testing Product and Services
        7.15.4 Siemens Healthineers Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 Siemens Healthineers Recent Developments/Updates
        7.15.6 Siemens Healthineers Competitive Strengths & Weaknesses
    7.16 Thermo Fisher Scientific
        7.16.1 Thermo Fisher Scientific Details
        7.16.2 Thermo Fisher Scientific Major Business
        7.16.3 Thermo Fisher Scientific Infectious Disease Biomarker Testing Product and Services
        7.16.4 Thermo Fisher Scientific Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
        7.16.5 Thermo Fisher Scientific Recent Developments/Updates
        7.16.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Infectious Disease Biomarker Testing Industry Chain
    8.2 Infectious Disease Biomarker Testing Upstream Analysis
    8.3 Infectious Disease Biomarker Testing Midstream Analysis
    8.4 Infectious Disease Biomarker Testing Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Infectious Disease Biomarker Testing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Infectious Disease Biomarker Testing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Infectious Disease Biomarker Testing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Infectious Disease Biomarker Testing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Infectious Disease Biomarker Testing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Infectious Disease Biomarker Testing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Infectious Disease Biomarker Testing Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Infectious Disease Biomarker Testing Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Infectious Disease Biomarker Testing Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Infectious Disease Biomarker Testing Players in 2022
    Table 12. World Infectious Disease Biomarker Testing Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Infectious Disease Biomarker Testing Company Evaluation Quadrant
    Table 14. Head Office of Key Infectious Disease Biomarker Testing Player
    Table 15. Infectious Disease Biomarker Testing Market: Company Product Type Footprint
    Table 16. Infectious Disease Biomarker Testing Market: Company Product Application Footprint
    Table 17. Infectious Disease Biomarker Testing Mergers & Acquisitions Activity
    Table 18. United States VS China Infectious Disease Biomarker Testing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Infectious Disease Biomarker Testing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Infectious Disease Biomarker Testing Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Infectious Disease Biomarker Testing Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Infectious Disease Biomarker Testing Revenue Market Share (2018-2023)
    Table 23. China Based Infectious Disease Biomarker Testing Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Infectious Disease Biomarker Testing Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Infectious Disease Biomarker Testing Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Infectious Disease Biomarker Testing Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Infectious Disease Biomarker Testing Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Infectious Disease Biomarker Testing Revenue Market Share (2018-2023)
    Table 29. World Infectious Disease Biomarker Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Infectious Disease Biomarker Testing Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Infectious Disease Biomarker Testing Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Infectious Disease Biomarker Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Infectious Disease Biomarker Testing Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Infectious Disease Biomarker Testing Market Size by Application (2024-2029) & (USD Million)
    Table 35. Abacus Diagnostica Basic Information, Area Served and Competitors
    Table 36. Abacus Diagnostica Major Business
    Table 37. Abacus Diagnostica Infectious Disease Biomarker Testing Product and Services
    Table 38. Abacus Diagnostica Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Abacus Diagnostica Recent Developments/Updates
    Table 40. Abacus Diagnostica Competitive Strengths & Weaknesses
    Table 41. ALPCO Basic Information, Area Served and Competitors
    Table 42. ALPCO Major Business
    Table 43. ALPCO Infectious Disease Biomarker Testing Product and Services
    Table 44. ALPCO Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. ALPCO Recent Developments/Updates
    Table 46. ALPCO Competitive Strengths & Weaknesses
    Table 47. Abbott Laboratories Basic Information, Area Served and Competitors
    Table 48. Abbott Laboratories Major Business
    Table 49. Abbott Laboratories Infectious Disease Biomarker Testing Product and Services
    Table 50. Abbott Laboratories Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Abbott Laboratories Recent Developments/Updates
    Table 52. Abbott Laboratories Competitive Strengths & Weaknesses
    Table 53. Agilent Technologies Basic Information, Area Served and Competitors
    Table 54. Agilent Technologies Major Business
    Table 55. Agilent Technologies Infectious Disease Biomarker Testing Product and Services
    Table 56. Agilent Technologies Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Agilent Technologies Recent Developments/Updates
    Table 58. Agilent Technologies Competitive Strengths & Weaknesses
    Table 59. Becton Basic Information, Area Served and Competitors
    Table 60. Becton Major Business
    Table 61. Becton Infectious Disease Biomarker Testing Product and Services
    Table 62. Becton Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Becton Recent Developments/Updates
    Table 64. Becton Competitive Strengths & Weaknesses
    Table 65. Dickinson and Company Basic Information, Area Served and Competitors
    Table 66. Dickinson and Company Major Business
    Table 67. Dickinson and Company Infectious Disease Biomarker Testing Product and Services
    Table 68. Dickinson and Company Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Dickinson and Company Recent Developments/Updates
    Table 70. Dickinson and Company Competitive Strengths & Weaknesses
    Table 71. bioMérieux SA Basic Information, Area Served and Competitors
    Table 72. bioMérieux SA Major Business
    Table 73. bioMérieux SA Infectious Disease Biomarker Testing Product and Services
    Table 74. bioMérieux SA Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. bioMérieux SA Recent Developments/Updates
    Table 76. bioMérieux SA Competitive Strengths & Weaknesses
    Table 77. Bio-Rad Laboratories Basic Information, Area Served and Competitors
    Table 78. Bio-Rad Laboratories Major Business
    Table 79. Bio-Rad Laboratories Infectious Disease Biomarker Testing Product and Services
    Table 80. Bio-Rad Laboratories Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Bio-Rad Laboratories Recent Developments/Updates
    Table 82. Bio-Rad Laboratories Competitive Strengths & Weaknesses
    Table 83. Danaher Basic Information, Area Served and Competitors
    Table 84. Danaher Major Business
    Table 85. Danaher Infectious Disease Biomarker Testing Product and Services
    Table 86. Danaher Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Danaher Recent Developments/Updates
    Table 88. Danaher Competitive Strengths & Weaknesses
    Table 89. F. Hoffmann-La Roche Basic Information, Area Served and Competitors
    Table 90. F. Hoffmann-La Roche Major Business
    Table 91. F. Hoffmann-La Roche Infectious Disease Biomarker Testing Product and Services
    Table 92. F. Hoffmann-La Roche Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. F. Hoffmann-La Roche Recent Developments/Updates
    Table 94. F. Hoffmann-La Roche Competitive Strengths & Weaknesses
    Table 95. Hologic Basic Information, Area Served and Competitors
    Table 96. Hologic Major Business
    Table 97. Hologic Infectious Disease Biomarker Testing Product and Services
    Table 98. Hologic Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Hologic Recent Developments/Updates
    Table 100. Hologic Competitive Strengths & Weaknesses
    Table 101. PerkinElmer Basic Information, Area Served and Competitors
    Table 102. PerkinElmer Major Business
    Table 103. PerkinElmer Infectious Disease Biomarker Testing Product and Services
    Table 104. PerkinElmer Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. PerkinElmer Recent Developments/Updates
    Table 106. PerkinElmer Competitive Strengths & Weaknesses
    Table 107. Qiagen Basic Information, Area Served and Competitors
    Table 108. Qiagen Major Business
    Table 109. Qiagen Infectious Disease Biomarker Testing Product and Services
    Table 110. Qiagen Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Qiagen Recent Developments/Updates
    Table 112. Qiagen Competitive Strengths & Weaknesses
    Table 113. Quest Diagnostics Incorporated Basic Information, Area Served and Competitors
    Table 114. Quest Diagnostics Incorporated Major Business
    Table 115. Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Product and Services
    Table 116. Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. Quest Diagnostics Incorporated Recent Developments/Updates
    Table 118. Quest Diagnostics Incorporated Competitive Strengths & Weaknesses
    Table 119. Siemens Healthineers Basic Information, Area Served and Competitors
    Table 120. Siemens Healthineers Major Business
    Table 121. Siemens Healthineers Infectious Disease Biomarker Testing Product and Services
    Table 122. Siemens Healthineers Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 123. Siemens Healthineers Recent Developments/Updates
    Table 124. Thermo Fisher Scientific Basic Information, Area Served and Competitors
    Table 125. Thermo Fisher Scientific Major Business
    Table 126. Thermo Fisher Scientific Infectious Disease Biomarker Testing Product and Services
    Table 127. Thermo Fisher Scientific Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 128. Global Key Players of Infectious Disease Biomarker Testing Upstream (Raw Materials)
    Table 129. Infectious Disease Biomarker Testing Typical Customers
List of Figure
    Figure 1. Infectious Disease Biomarker Testing Picture
    Figure 2. World Infectious Disease Biomarker Testing Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Infectious Disease Biomarker Testing Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Infectious Disease Biomarker Testing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Infectious Disease Biomarker Testing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Infectious Disease Biomarker Testing Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Infectious Disease Biomarker Testing Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Infectious Disease Biomarker Testing Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Infectious Disease Biomarker Testing Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Infectious Disease Biomarker Testing Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Infectious Disease Biomarker Testing Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Infectious Disease Biomarker Testing Revenue (2018-2029) & (USD Million)
    Figure 13. Infectious Disease Biomarker Testing Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Infectious Disease Biomarker Testing Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Infectious Disease Biomarker Testing Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Infectious Disease Biomarker Testing by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Infectious Disease Biomarker Testing Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Infectious Disease Biomarker Testing Markets in 2022
    Figure 27. United States VS China: Infectious Disease Biomarker Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Infectious Disease Biomarker Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Infectious Disease Biomarker Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Infectious Disease Biomarker Testing Market Size Market Share by Type in 2022
    Figure 31. PCR
    Figure 32. NGS
    Figure 33. ELISA or EIA
    Figure 34. IHC
    Figure 35. ISH
    Figure 36. Others
    Figure 37. World Infectious Disease Biomarker Testing Market Size Market Share by Type (2018-2029)
    Figure 38. World Infectious Disease Biomarker Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 39. World Infectious Disease Biomarker Testing Market Size Market Share by Application in 2022
    Figure 40. Hospitals and Clinics
    Figure 41. Diagnostic Centers
    Figure 42. Academic Research Institutes
    Figure 43. Others
    Figure 44. Infectious Disease Biomarker Testing Industrial Chain
    Figure 45. Methodology
    Figure 46. Research Process and Data Source